graphy revealed that at least a part of the GAG in thyroid carcinoma tissue was present in macromolecule form and the molecular size became smaller when treated with papain or alkaline borohydride.
The results indicated that those fractions of GAG were present as proteoglycans. The GAG was composed of a mixture of heparan sulfate and chondroitin sulfate or dermatan sulfate in one carcinoma tissue and mainly composed of chondroitin sulfate or dermatan sulfate in the other. The mechanism of the increase in proteoglycan and GAG remains to be elucidated.
In our previous study, we have demonstrated the presence of heparan sulfate glycosaminoglycan (GAG) at least in part in a form of proteoglycan in normal thyroid. tissue (Shishiba et al., 1 9 8 3) . As proteoglycans were known to provide a good milieu for cell growth and development, in the present study, we sought to determine whether GAG's in a form of proteoglycan chromatography was performed employing Sepharose 2B and 6B. When the D1 fraction obtained from patient #792301 with thyroid carcinoma was analyzed with Sepharose 6B columns, as shown in Fig. 1 , A, hexuronic acid was eluted in two peaks, 22.9% at void volume (Vo) and another 77.7% at Kav=0.23. The protein peak was observed only at Vo (not shown in the figure). When the D1 fraction was digested with papain, the peak at Vo disappeared, a peak at Kav=0.23 was unchanged and a new peak appeared at Vt (Fig. 1, B) . Thus, the peak eluted at void volume represents proteoglycan and the peak eluted at Kav=0.23 represents the single GAG chain because the elution position of the peak was not changed with papain digestion. When the D1 fraction was analyzed by Sepharose 2B column and was treated with alkaline borohydride, the peak at Vo (15.3% of hexuronic acid) disappeared, the peak at Kav=0.64 was unchanged, and a peak appeared at Kav= 0.9 (Fig. 2, A and B) . The peak at void volume represents proteoglycan and the peak at Kav=0.64 probably represents the single GAG chain because the former disappeared and the latter stayed at the same elution position after alkaline borohydride treatment which is known to release GAG by elimination reaction.
When the D1 fraction was treated with chondroitinase ABC and chromatographed with a Sepharose 6B column, there was a proportional reduction in hexuronic acid content in the fraction eluted at Vo (from 22.9 to 16.8%) and Kav=0.23 (from 77.7 to 34.7%) and a new peak (48.5% of hexuronic acid) appeared at Kav=0.9 (Fig. 3, A and B) .
These results indicate that approximately 30% to 55% of GAG's are composed of chondroitin sulfate or dermatan sulfate. Treatment of D1 fraction with nitrous acid reduced the hexuronic acid peak at Vo considerably and a small peak (approximately 60%) remained at Kav=0.23, indicating that the remaining portion (approximately The D1 fraction obtained from patient #800052 with thyroid carcinoma presented a different pattern of GAG distribution on chromatographic analysis. Hexuronic acid was eluted in a broad peak at Kav=0.13 (Fig. 4, A) . A protein peak was observed at the same position.
With the papain digestion, the hexuronic acid peak at Kav= 0.13 decreased and a new peak appeared at Kav=0.47 (Fig. 4, B) . Alkaline boro- hydride treatment caused a similar change (Fig 4, C) . Thus, the results suggested that at least a part of GAG (approximately 12%) existed as a form of proteoglycan. From the fact that the remaining 88% of GAG was eluted at Kay =0.13 even after the treatment with papain or alkaline borohydride, the following two explanations are possible : One is that the major portion of GAG (approximately 88%) existing as proteoglycan was rather resistant to the effect of papain or alkaline borohydride. Another explanation is that the size of GAG of this patient was heterogeneous.
Smaller sized GAG consisted of proteoglycan and was eluted at Kav=0.47 when treated with papain or alkaline borohydride. Larger sized GAG (eluted at Kay = 0.13) existed as single GAG chain with very small amounts of covalently linked peptide, if any. Nitrous acid treatment after alkaline borohydride treatment caused only a minor change on the chromatographic elution pattern of hexuronic acid (Fig. 4, D) . When the D1 fraction was treated with chondroitinase ABC, and analyzed with a Sepharose 2B column, the peaks presenting a high molecular form of hexuronic acid disappeared and the peak at Vt was increased (Fig. 5, B) . These results suggested that the GAG of this patient was mainly composed of chondroitin sulfate or dermatan sulfate.
In the remaining three cases, analysis of the GAG was not possible because of the paucity of excised surgical materials.
Discussion
The present study demonstrated a definite increase in GAG in human thyroid carcinoma tissue for the first time. The amount of GAG in thyroid carcinoma tissue ranged from 6 to 15 fold of that of normal (Shishiba et al., 1983) , while that of thyroid adenoma tissue ranged from 2 to 3 fold. The present study also demonstrated that a part of the GAG (approximately 15-23% in case #792301 and at least approximately 12% in case #800052) was present as proteoglycans. From the elution position shown in Fig. 1A, 2A and 4A, the molecular weight of proteoglycan was estimated to be more than 4 million. The nature of GAG in thyroid carcinoma tissue was different from case to case. For example, in case #792301 approximately 40% of GAG was composed of chondroitin sulfate or dermatan sulfate (sensitive to chondroitinase ABC) and the remaining 60% was heparin or heparan sulfate (sensitive to nitrous acid), while that in case #800052 was almost exclusively composed of chondroitin sulfate or dermatan sulfate (sensitive to chondroitinase ABC).
Despite the use of strong denaturing (dissociative) conditions of 4M guanidine HCl and protease inhibitors throughout the extraction and purification procedures, approximately 60% to 80% of the GAG in case #4792301 and possibly 88% of GAG in case #800052 were present as a single GAG chain, suggesting proteolytic degradation of proteoglycans. The nature of this proteolysis, whether this represents a physiological process or experimental artifacts remains to be studied.
The molecular weight of this single chain species of GAG was estimated to be more than 50,000 based on the published data on the calibration of Sepharose 6B column by chondroitin sulfate (Wasteson, 1971) . Although it was not possible to analyze GAG's in the remaining three cases because of the paucity of surgical materials we speculated that at least a part of the GAG was present as proteoglycans as in the two cases described.
The reason why proteoglycans increase in thyroid carcinoma tissue remains to be elucidated. As proteoglycans are the constituents of various biological materials such as connective tissue, basement membranes or plasma membranes of cells, there are number of possible explanations for its increase (Roden, 1980) . Whatever the mechanism and the site of increase, the accumulation of proteoglycan in human thyroid carcinoma may possibly provide a good marker for this neoplasma.
